OSXB3
ONconsolidatedOSX BRASIL S.A. - Em Recuperação Judicial
CNPJ 09112685000132
—
Ratios
Q3 25 → Q2 26Share capital from the FRE dated 2025-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.
computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.
Ratios by year
| Year | Revenue | Net income | Gross margin | Net margin | ROE | ROA | Turnover | Year-end price | P/E | DY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 82.66m | -1.11bn | 100.0% | -1,339.1% | — | -160.2% | 0.12 | 1.98 | — | — |
| 2024 | 64.42m | -1.59bn | 100.0% | -2,470.2% | — | -114.3% | 0.05 | 3.61 | — | — |
| 2023 | 45.25m | -1.19bn | 100.0% | -2,632.4% | — | -50.3% | 0.02 | 4.23 | — | — |
| 2022 | 35.08m | -288.42m | 90.8% | -822.1% | — | -10.5% | 0.01 | 6.56 | — | — |
| 2021 | 26.41m | 122.86m | 90.2% | 465.3% | — | 5.5% | 0.01 | 6.82 | 0.17 | — |
| 2020 | 10.03m | -871.91m | 100.0% | -8,692.2% | — | -58.6% | 0.01 | 20.28 | — | — |
| 2019 | 12.01m | -568.63m | 100.0% | -4,733.4% | — | -28.3% | 0.01 | 3.27 | — | — |
| 2018 | 9.06m | -427.58m | 100.0% | -4,719.4% | — | -24.6% | 0.01 | 3.45 | — | — |
| 2017 | 10.63m | -502.70m | 100.0% | -4,729.5% | — | -28.8% | 0.01 | 7.66 | — | — |
| 2016 | 1.09m | -1.45bn | -570.6% | -132,283.2% | — | -85.7% | 0.00 | 15.00 | — | — |
| 2015 | 414.20m | -987.35m | 18.4% | -238.4% | — | -11.9% | 0.05 | 0.15 | — | — |
| 2014 | 731.08m | -4.24bn | 24.9% | -579.5% | — | -70.0% | 0.12 | 0.25 | — | — |
| 2013 | 745.12m | -2.40bn | 59.2% | -322.1% | -108.9% | -28.1% | 0.09 | 0.61 | — | — |
| 2012 | 433.77m | -32.72m | 40.0% | -7.5% | -1.0% | -0.3% | 0.04 | 10.65 | — | — |
| 2011 | 144.23m | 4.69m | 43.5% | 3.3% | 0.2% | 0.1% | 0.03 | 11.50 | — | — |
| 2010 | 8.83m | -77.18m | 6.4% | -873.6% | -3.2% | -2.3% | 0.00 | 483.00 | — | — |
From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.
Quarterly results
| Period | Revenue | Operating | Net income | Net margin |
|---|---|---|---|---|
| Q2 26 | 26.52m | 17.09m | -283.17m | -1,067.8% |
| Q1 26 | 21.82m | 2.43m | -284.80m | -1,305.5% |
| Q4 25 | 15.43m | -267.84m | -566.07m | -3,667.7% |
| Q3 25 | 24.01m | 44.39m | -25.64m | -106.8% |
| Q2 25 | 21.78m | -15.24m | -276.66m | -1,270.1% |
| Q1 25 | 21.43m | -4.67m | -238.46m | -1,112.9% |
| Q4 24 | 11.77m | -989.26m | -925.18m | -7,860.5% |
| Q3 24 | 18.68m | 24.36m | -175.73m | -940.8% |
| Q2 24 | 17.41m | -8.87m | -286.52m | -1,646.1% |
| Q1 24 | 16.56m | -5.12m | -195.93m | -1,182.8% |
| Q4 23 | 10.37m | -336.64m | -568.54m | -5,485.2% |
| Q3 23 | 14.74m | 4.42m | -206.54m | -1,401.2% |
Balance sheet
| Period | Total assets | Equity | Assets / Equity | Current ratio |
|---|---|---|---|---|
| Q2 26 | 703.99m | -10.49bn | — | 0.06 |
| Q1 26 | 696.70m | -10.20bn | — | 0.05 |
| Q4 25 | 690.94m | -9.92bn | — | 0.04 |
| Q3 25 | 1.49bn | -8.94bn | — | 0.04 |
| Q2 25 | 1.40bn | -8.92bn | — | 0.02 |
| Q1 25 | 1.39bn | -8.64bn | — | 0.01 |
| Q4 24 | 1.39bn | -8.40bn | — | 0.01 |
| Q3 24 | 2.37bn | -7.48bn | — | 0.01 |
| Q2 24 | 2.36bn | -7.30bn | — | 0.01 |
| Q1 24 | 2.37bn | -7.01bn | — | 0.01 |
| Q4 23 | 2.37bn | -6.81bn | — | 0.01 |
| Q3 23 | 2.72bn | -6.24bn | — | 0.02 |
A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.
What the company filed
| Filing | Period | Filed on | Days after close | Document |
|---|---|---|---|---|
| ITRT2 | 2026-06-30 | 2026-08-12 | 43 | CVM ↗ |
| ITRT1 | 2026-03-31 | 2026-05-13 | 43 | CVM ↗ |
| DFPanual | 2025-12-31 | 2026-03-31 | 90 | CVM ↗ |
| ITRT3 | 2025-09-30 | 2025-11-12 | 43 | CVM ↗ |
| ITRT2 | 2025-06-30 | 2025-08-14 | 45 | CVM ↗ |
| ITRT1 | 2025-03-31 | 2025-05-13 | 43 | CVM ↗ |
| DFPanual | 2024-12-31 | 2025-03-28 | 87 | CVM ↗ |
| ITRT3 | 2024-09-30 | 2024-11-13 | 44 | CVM ↗ |
| ITRT2 | 2024-06-30 | 2024-08-14 | 45 | CVM ↗ |
| ITRT1 | 2024-03-31 | 2024-05-13 | 43 | CVM ↗ |
| DFPanual | 2023-12-31 | 2024-03-28 | 88 | CVM ↗ |
| ITRT3 | 2023-09-30 | 2023-11-13 | 44 | CVM ↗ |
| ITRT2 | 2023-06-30 | 2023-08-11 | 42 | CVM ↗ |
| ITRT1 | 2023-03-31 | 2023-05-12 | 42 | CVM ↗ |
| DFPanual | 2022-12-31 | 2023-03-28 | 87 | CVM ↗ |
| ITRT3 | 2022-09-30 | 2022-11-11 | 42 | CVM ↗ |
When the next one is due
This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.